Uncertainty-Aware Alzheimer’s Disease Detection Using Bayesian Convolutional Neural Networks on MRI Images

Abstract

Alzheimer’s Disease (AD) is an escalating global health concern, with early diagnosis being crucial for effective intervention and therapeutic management. The advent of machine learning, particularly deep learning techniques, has revolutionized the analysis of magnetic resonance imaging (MRI) for the detection and staging of AD. However, existing models commonly provide deterministic predictions, overlooking the inherent uncertainty in medical image interpretation—a factor vital for clinical trust and decision-making. Bayesian convolutional neural networks (BCNNs) offer a promising solution by quantifying predictive uncertainty, thereby enhancing the reliability of automatic AD detection systems. This research paper provides a comprehensive analysis of uncertainty-aware AD detection using BCNNs on MRI images. We review the landscape of deep learning approaches in AD detection, highlight the significance of uncertainty quantification, and propose a conceptual framework for integrating Bayesian inference into convolutional neural network (CNN) architectures. The paper systematically incorporates insights from recent advances, including hybrid transformer models, multi-task learning, quantum-classical architectures, transfer learning, and dimensionality reduction, to contextualize the challenges and opportunities in uncertainty-aware AD detection. Diagrams and illustrative figures are included to elucidate model architectures and uncertainty estimation mechanisms. The study concludes by discussing future directions and the clinical implications of uncertainty-aware models in precision diagnostics of Alzheimer’s Disease.

Introduction

Alzheimer’s Disease (AD) is a widespread neurodegenerative disorder, affecting millions globally, with early detection at the Mild Cognitive Impairment (MCI) stage critical for effective intervention. MRI provides high-resolution, non-invasive imaging of structural brain changes, but subtle early-stage alterations are challenging to detect manually. Deep learning, particularly convolutional neural networks (CNNs), has become central to automated AD diagnosis, enhanced by transfer learning, hybrid CNN-transformer architectures, and emerging quantum-classical models.

A key limitation of standard deep learning models is their deterministic nature, producing predictions without confidence measures. Bayesian CNNs (BCNNs) overcome this by modeling uncertainty in predictions, offering probabilistic outputs that indicate confidence levels and guide clinical decision-making. BCNNs incorporate approximate Bayesian inference methods like Monte Carlo dropout, variational inference, and deep ensembles to quantify both model (epistemic) and data (aleatoric) uncertainty.

Methodology:

• MRI datasets (ADNI, OASIS) are preprocessed through skull-stripping, normalization, and slice extraction.

• CNN, hybrid CNN-transformer, and Bayesian layers extract hierarchical features and produce probabilistic predictions.

• Multi-task learning integrates AD detection with cognitive score prediction, while dimensionality reduction techniques (e.g., inertia tensor analysis) improve efficiency.

• Uncertainty visualization overlays high-confidence and ambiguous regions on MRI scans for clinician interpretation.

Findings & Advantages:

• Hybrid models and transfer learning achieve high classification accuracy for AD, MCI, and cognitively normal subjects.

• Bayesian approaches provide calibrated uncertainty estimates, enhancing clinical trust, highlighting ambiguous cases, and guiding active learning.

• Quantum-classical and dimensionality reduction methods reduce computational costs while maintaining performance.

Challenges:

• Bayesian inference is computationally intensive, particularly for 3D MRI volumes.

• Dataset variability, class imbalance, and limited labeled data can affect accuracy and uncertainty calibration.

• Translating uncertainty scores into actionable clinical insights remains an ongoing challenge.

Conclusion

Uncertainty-aware deep learning represents a significant advance in the automated detection of Alzheimer’s Disease from MRI images. Bayesian CNNs provide not only accurate classifications but also quantifiable measures of diagnostic confidence—a critical requirement for safe and effective clinical deployment. Integration with advanced architectures (transformers, quantum-classical hybrids), multi-task frameworks, and efficient feature extraction methods further enhances the robustness and applicability of these systems. Future research should focus on: 1) Developing scalable Bayesian inference techniques for 3D MRI data. 2) Improving calibration and interpretability of uncertainty measures. 3) Leveraging multi-modal data (MRI, PET, cognitive scores) within uncertainty-aware frameworks. 4) Conducting multi-site clinical validation to assess generalizability and trustworthiness. 5) Exploring the synergy between quantum computing and Bayesian deep learning for rapid, reliable AD detection in real-world settings. In sum, uncertainty-aware AI models hold the potential to revolutionize dementia diagnostics, providing clinicians with both diagnostic accuracy and the confidence necessary for informed decision-making.

References

[1] Jaiswal and A. Sadana, “Early Detection of Alzheimer’s Disease using Bottleneck Transformers,” arXiv:2305.00923v1. [Online]. Available: https://arxiv.org/pdf/2305.00923v1 [2] A. Ben Miled, T. Yeferny, and A. ben Rabeh, “MRI Images Analysis Method for Early Stage Alzheimer’s Disease Detection,” IJCSNS International Journal of Computer Science and Network Security, vol. 20, no. 9, 2020. [Online]. Available: https://arxiv.org/pdf/2012.00830v1 [3] K. Mahapatra and S. R, “Detection of Alzheimer’s Disease using MRI scans based on Inertia Tensor and Machine Learning,” arXiv:2304.13314v1. [Online]. Available: https://arxiv.org/pdf/2304.13314v1 [4] X. Tian, J. Liu, H. Kuang, Y. Sheng, J. Wang, and the Alzheimer’s Disease Neuroimaging Initiative, “MRI-based Multi-task Decoupling Learning for Alzheimer’s Disease Detection and MMSE Score Prediction: A Multi-site Validation,” arXiv:2204.01708v3. [Online]. Available: https://arxiv.org/pdf/2204.01708v3 [5] M. Islam, M. J. Hasan, and M. R. C. Mahdy, “CQ CNN: A Hybrid Classical Quantum Convolutional Neural Network for Alzheimer’s Disease Detection Using Diffusion Generated and U Net Segmented 3D MRI,” arXiv:2503.02345v1. [Online]. Available: https://arxiv.org/pdf/2503.02345v1 [6] S. Alam et al., “Dual-tree complex wavelet transforms and the machine learning model SVM for Alzheimer’s detection,” as cited in [2]. [7] X. Tian et al., “MRI-based Multi-task Decoupling Learning for Alzheimer’s Disease Detection and MMSE Score Prediction: A Multi-site Validation,” as cited in [4]. [8] M. Islam et al., “CQ CNN: A Hybrid Classical Quantum Convolutional Neural Network for Alzheimer’s Disease Detection Using Diffusion Generated and U Net Segmented 3D MRI,” as cited in [5]. [9] K. Mahapatra and S. R, “Detection of Alzheimer’s Disease using MRI scans based on Inertia Tensor and Machine Learning,” as cited in [3]. [10] A. Jaiswal and A. Sadana, “Early Detection of Alzheimer’s Disease using Bottleneck Transformers,” as cited in [1]. [11] A. Ben Miled et al., “MRI Images Analysis Method for Early Stage Alzheimer’s Disease Detection,” as cited in [2]. [12] J. Henry, Kaiser Family Foundation, “Percent of Men who Report Having No Personal Doctor/Health Care Provider, by Race/ Ethnicity”, 2019, as cited in [2]. [13] F. Ramzan et al., “ResNet18 network for AD detection,” as cited in [2].

Copyright

Copyright © 2025 Mr. Bhushan Sanjiv Patil, Prof. M. V. Budhe. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.